Last reviewed · How we verify

Bronchodilators inhalation

Dr. J. Alberto Neder · FDA-approved active Small molecule

Bronchodilators relax airway smooth muscle to widen airways and improve airflow to the lungs.

Bronchodilators relax airway smooth muscle to widen airways and improve airflow to the lungs. Used for Asthma, Chronic obstructive pulmonary disease (COPD), Reversible airway obstruction.

At a glance

Generic nameBronchodilators inhalation
Also known asSalmeterol/fluticasone (Seretide Evohaler), fenoterol (Berotec)(0.1mg/puff)
SponsorDr. J. Alberto Neder
Drug classBronchodilator (inhalation)
TargetBeta-2 adrenergic receptor or muscarinic receptor (class-dependent)
ModalitySmall molecule
Therapeutic areaRespiratory
PhaseFDA-approved

Mechanism of action

Bronchodilators work by stimulating beta-2 adrenergic receptors (beta-agonists) or blocking muscarinic receptors (anticholinergics) on airway smooth muscle, causing relaxation and bronchodilation. This reduces airway resistance and improves ventilation, making breathing easier for patients with obstructive airway diseases.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results